Pharma & Biotech

Waltz Health and Fresenius Kabi are moving to offer three biosimilars through a direct-to-payer model, bypassing traditional wholesaler and pharmacy benefit manager rebate channels entirely. The partnership represents a significant shift in

Novo Nordisk’s chief executive has signalled openness to listing the Danish drugmaker’s shares directly on the New York Stock Exchange. CEO Doustdar told a newspaper that he sees clear advantages in pursuing

The CPHI Milan Leadership Summit is set to return with a sharp focus on supply chain resilience, one of the pharmaceutical industry’s most pressing concerns heading into late 2026. Supply chain disruption

Sun Pharmaceutical Industries Limited has unveiled a new educational campaign called Regrowth Restyled, aimed at supporting adults living with severe alopecia areata. The campaign launched during Alopecia Areata Awareness Month and takes

Eli Lilly (LLY) has secured a second FDA approval for its oral SERD Inluriyo in under a year, this time in combination with its CDK4/6 inhibitor Verzenio. The regimen is now approved

The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended 12 new medicines for approval at its September 2026 meeting. The CHMP also backed extensions of indication for 11 existing

Bavarian Nordic A/S (OMX: BAVA) has appointed Tarja Stenvall as President and Chief Executive Officer, effective October 15, 2026, succeeding longtime leader Paul Chaplin. Stenvall brings more than 20 years of global

Bayer’s Kerendia has secured a third FDA approval, becoming the first new therapeutic advance for chronic kidney disease linked to type 1 diabetes in more than three decades. The US regulator approved

Ultragenyx Pharmaceutical has won FDA approval for its gene therapy Fayuvi, marking a historic milestone for children diagnosed with a rare and fatal neurodegenerative disorder. The U.S. Food and Drug Administration granted